Shi Jiao

3.8k total citations · 4 hit papers
54 papers, 3.0k citations indexed

About

Shi Jiao is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Shi Jiao has authored 54 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Cell Biology and 12 papers in Immunology. Recurrent topics in Shi Jiao's work include Hippo pathway signaling and YAP/TAZ (25 papers), RNA Research and Splicing (7 papers) and Cellular Mechanics and Interactions (5 papers). Shi Jiao is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (25 papers), RNA Research and Splicing (7 papers) and Cellular Mechanics and Interactions (5 papers). Shi Jiao collaborates with scholars based in China, United States and South Korea. Shi Jiao's co-authors include Zhaocai Zhou, Zhubing Shi, Wenjia Wang, Haijun Yu, Bing Feng, Fangyuan Zhou, Yaping Li, Dangge Wang, Yun Zhao and Feng He and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Shi Jiao

54 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer

2014 505 citations Shi Jiao, Huizhen Wang et al. Cancer Cell profile →
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy

2016 376 citations Haijun Yu, Shi Jiao et al. profile →
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors

2018 355 citations Haijun Yu, Shi Jiao et al. Nature Communications profile →
The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer

2024 148 citations Junyi Ju, Hui Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shi Jiao China	26	1.6k	1.0k	735	590	510	54	3.0k
Juliane Winkler Germany	15	1.8k 1.1×	633 0.6×	369 0.5×	399 0.7×	668 1.3×	20	2.9k
Curtis B. Thompson United States	24	1.3k 0.8×	514 0.5×	430 0.6×	281 0.5×	1.1k 2.2×	51	2.6k
Masanobu Komatsu United States	28	1.7k 1.0×	390 0.4×	457 0.6×	227 0.4×	752 1.5×	66	2.9k
Theerawut Chanmee Thailand	11	879 0.5×	362 0.3×	797 1.1×	271 0.5×	735 1.4×	13	2.1k
Pingwei Xu China	20	1.1k 0.7×	232 0.2×	511 0.7×	451 0.8×	366 0.7×	23	2.1k
Stefanie K. Wculek Spain	18	1.6k 1.0×	435 0.4×	2.8k 3.8×	536 0.9×	1.8k 3.5×	21	4.7k
Santiago Rello‐Varona Spain	20	872 0.5×	336 0.3×	575 0.8×	305 0.5×	614 1.2×	32	2.1k
Oliver M.T. Pearce United Kingdom	23	1.3k 0.8×	304 0.3×	923 1.3×	172 0.3×	623 1.2×	43	2.5k
Nikolaos A. Afratis Greece	16	1.0k 0.7×	824 0.8×	153 0.2×	195 0.3×	367 0.7×	27	2.1k

Countries citing papers authored by Shi Jiao

Since Specialization

Citations

This map shows the geographic impact of Shi Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Jiao more than expected).

Fields of papers citing papers by Shi Jiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Jiao. The network helps show where Shi Jiao may publish in the future.

Co-authorship network of co-authors of Shi Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Jiao. A scholar is included among the top collaborators of Shi Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Jiao. Shi Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Yang, Ge‐Min Fang, Hui Zhang, et al.. (2024). A cofactor-induced repressive type of transcription factor condensation can be induced by synthetic peptides to suppress tumorigenesis. The EMBO Journal. 43(22). 5586–5612. 3 indexed citations

Wang, Shilong, et al.. (2024). Modeling human gastric cancers in immunocompetent mice. Cancer Biology and Medicine. 21(7). 1–18. 4 indexed citations

Zhao, Qiudong, Yan Sang, Fei Ye, et al.. (2023). GPNMB ⁺ Gal‐3 ⁺ hepatic parenchymal cells promote immunosuppression and hepatocellular carcinogenesis. The EMBO Journal. 42(24). e114060–e114060. 8 indexed citations

Jiao, Shi, Chuanchuan Li, Fenghua Guo, et al.. (2023). SUN1/2 controls macrophage polarization via modulating nuclear size and stiffness. Nature Communications. 14(1). 6416–6416. 19 indexed citations

Cao, Zhifa, Liwei An, Yi Han, Shi Jiao, & Zhaocai Zhou. (2023). The Hippo signaling pathway in gastric cancer. Acta Biochimica et Biophysica Sinica. 55(6). 893–903. 15 indexed citations

Lu, Xiaoqing, Liwei An, Guangjian Fan, et al.. (2022). EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription. Cell Research. 32(4). 359–374. 54 indexed citations

Meng, Yan, Qiudong Zhao, Liwei An, et al.. (2021). A TNFR2–hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells. Cancer Research. 81(11). 3036–3050. 74 indexed citations

Zhou, Fengqi, Jing Gao, Yang Tang, et al.. (2021). Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer. Advanced Materials. 33(43). e2102668–e2102668. 58 indexed citations

Tang, Yang, Ge‐Min Fang, Fenghua Guo, et al.. (2020). Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer. Cancer Cell. 38(1). 115–128.e9. 94 indexed citations

10.

Li, Yehua, Jingmin Guan, Wenjia Wang, et al.. (2018). TRAF3-interacting JNK-activating modulator promotes inflammation by stimulating translocation of Toll-like receptor 4 to lipid rafts. Journal of Biological Chemistry. 294(8). 2744–5499. 14 indexed citations

11.

Jiao, Shi, Chuanchuan Li, Hao Qian, et al.. (2017). VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer. Nature Communications. 8(1). 14058–14058. 118 indexed citations

12.

Qian, Hao, Shi Jiao, Zhubing Shi, et al.. (2015). A non‐canonical role of the p97 complex in RIG ‐I antiviral signaling. The EMBO Journal. 34(23). 2903–2920. 42 indexed citations

13.

Shi, Zhubing, Zhen Zhang, Zhenzhen Zhang, et al.. (2015). Structural Insights into Mitochondrial Antiviral Signaling Protein (MAVS)-Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Signaling. Journal of Biological Chemistry. 290(44). 26811–26820. 38 indexed citations

14.

Zhang, Zhao, Yanyan Wang, Chuanchuan Li, et al.. (2015). The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100. Journal of Biological Chemistry. 290(32). 19558–19568. 22 indexed citations

15.

Liu, Guoguang, Zhubing Shi, Shi Jiao, et al.. (2014). Structure of MST2 SARAH domain provides insights into its interaction with RAPL. Journal of Structural Biology. 185(3). 366–374. 14 indexed citations

16.

Jiao, Shi, Huizhen Wang, Zhubing Shi, et al.. (2014). A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer. Cancer Cell. 25(2). 166–180. 505 indexed citations breakdown →

17.

Feng, Miao, Zhanyu Ding, Liang Xu, et al.. (2012). Structural and biochemical studies of RIG-I antiviral signaling. Protein & Cell. 4(2). 142–154. 21 indexed citations

18.

Xue, Jing, Dandan Lv, Shi Jiao, et al.. (2012). pVHL Mediates K63-Linked Ubiquitination of nCLU. PLoS ONE. 7(4). e35848–e35848. 18 indexed citations

19.

Jiao, Shi, Bingci Liu, Ai Gao, et al.. (2008). Benzo(a)pyrene-caused increased G1–S transition requires the activation of c-Jun through p53-dependent PI-3K/Akt/ERK pathway in human embryo lung fibroblasts. Toxicology Letters. 178(3). 167–175. 22 indexed citations

20.

Gao, Ai, Bingci Liu, Xianglin Shi, et al.. (2007). Phosphatidylinositol-3 kinase/Akt/p70S6K/AP-1 signaling pathway mediated benzo(a)pyrene-induced cell cycle alternation via cell cycle regulatory proteins in human embryo lung fibroblasts. Toxicology Letters. 170(1). 30–41. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact